Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine.
about
Brief History and Characterization of Enhanced Respiratory Syncytial Virus DiseaseImmunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in miceRespiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Receptor characterization and susceptibility of cotton rats to avian and 2009 pandemic influenza virus strainsNewcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.Inactivation of respiratory syncytial virus by zinc finger reactive compounds.Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model.Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.Immune responses and disease enhancement during respiratory syncytial virus infectionThe cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies.Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.Immunoprotective activity and safety of a respiratory syncytial virus vaccine: mucosal delivery of fusion glycoprotein with a CpG oligodeoxynucleotide adjuvant.New insights for development of a safe and protective RSV vaccineNucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infectionGinseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses.Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins.Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells.Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton ratsSmall Animal Models for Human Metapneumovirus: Cotton Rat is More Permissive than Hamster and Mouse.Immunization strategies for the prevention of pneumovirus infections.Immunoprophylaxis of respiratory syncytial virus: global experience.A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles.Protective and dysregulated T cell immunity in RSV infectionNovel drugs targeting Toll-like receptors for antiviral therapy.Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV diseaseRecombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease.RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsetsHost proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expressionHuman metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune CellsInterleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.Antisense approaches for inhibiting respiratory syncytial virus.Carriers for the delivery of a vaccine against respiratory syncytial virus.A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton ratsCotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein.Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.
P2860
Q26775152-E14A6DB5-AB4F-4766-8FE7-6D9310BCA3BFQ28730052-85FDF195-2D66-4E8F-BA64-1EAFE3ED74D4Q30240274-E889AEDC-85DB-48EE-93E1-C2C63DC9413AQ30424191-3E45E553-C63F-4AA0-87E1-2B7C0FA77204Q33558475-F3F43347-32CF-4CD7-81A7-24D8A3D3C637Q33663190-C3B0BD6C-525D-461C-B368-9EF99D0796F0Q33724997-B0A603B3-0047-49E3-BC1C-83EA6C3864E4Q33901537-C6A33853-5A55-4A2F-BF97-C0E60017101AQ33908872-D149D577-0232-446B-92C2-BDE95DB753C7Q33937152-D18F8A29-A376-4F3A-8DDB-8B7FE2BF0F60Q34142834-6826E260-5104-4956-BF81-3B9D3389A09AQ34224973-09AD836F-8275-4488-AC06-A2722DECD612Q34226850-E832853E-3434-4FD6-96E1-69543EF04E83Q34249859-309AE708-A00C-4AC7-8F5B-62C8E37AC03DQ34289051-745ADE22-D451-4EAA-AA97-DC9BB62E310FQ34355131-E695276D-9B2E-464F-8C3F-9C388BF4E002Q34440116-03E07730-2A21-4DBC-8196-03D41E05BB49Q34457791-205F293D-7BB7-4BA6-AF08-973C994B4C8DQ34465367-278391BD-6312-4ADD-969F-CF7B4C8DAD5BQ34506016-2FA378C3-5F74-420E-97CE-E07D1877506CQ34569141-F6E7FE4D-B095-405C-B3C4-05F527A31DDDQ34615678-D69466A2-7AD5-4D91-8D54-8AC42ECC6C32Q34740842-FE47B073-926A-482D-B190-2033256AC45EQ34948645-5FE3D3A2-A782-4481-8A2D-0ADB36C8E647Q34964939-10EAD187-E537-4CBF-B66F-7AF4F09F03A5Q34999938-177FFBBD-AC0F-4D19-9EE9-63FD1EEAE4F2Q35070176-A6F1AECE-773D-42F0-9317-FEB0898CE3F6Q35070505-AC2546BD-B21D-4D32-B27A-2EC34D94E4ACQ35174945-98E8FF47-6248-40BC-8B60-8CFAFE90EF5EQ35488618-FC5C86E8-E777-447C-AFD3-A2EF799A8C34Q35634924-FE553E64-ED3E-41C2-A5AC-E4F6D7E42CC2Q35634929-720EC8DA-A161-4E09-A02C-A6CD0F5C43EAQ35808047-0D777451-1A0E-432B-83B2-B57930047E22Q35868095-5CCEBE6B-50CC-4076-A266-CB63678EC7A0Q36065956-CB7349E7-02A9-4E37-8E43-F05E5049347CQ36194078-267CFE10-B346-4F91-9065-D6E80F17019DQ36251566-EDF0F946-5268-4FF2-9BA6-607B66D97168Q36256989-9B8D06BC-15A3-48DB-9361-B8D593AE00F3Q36281893-C7A3DE0D-00B3-47B1-BD87-CD6BDBD98C40Q36363236-9EDACB80-289E-488B-B7E3-C6223788E485
P2860
Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Vaccine-enhanced respiratory s ...... ly prepared reference vaccine.
@en
Vaccine-enhanced respiratory s ...... ly prepared reference vaccine.
@nl
type
label
Vaccine-enhanced respiratory s ...... ly prepared reference vaccine.
@en
Vaccine-enhanced respiratory s ...... ly prepared reference vaccine.
@nl
prefLabel
Vaccine-enhanced respiratory s ...... ly prepared reference vaccine.
@en
Vaccine-enhanced respiratory s ...... ly prepared reference vaccine.
@nl
P2093
P1476
Vaccine-enhanced respiratory s ...... ly prepared reference vaccine.
@en
P2093
P304
P356
10.1099/0022-1317-82-12-2881
P407
P577
2001-12-01T00:00:00Z